November 5, 2015 — A wrongful death lawsuit has been filed by the daughter of a woman who died from heart failure after taking AstraZeneca’s diabetes drug Onglyza.
The plaintiff, Rochelle Gibson, is a resident of Chicago who filed the lawsuit on behalf of her mother, Lillie Ree Gibson. The complaint was filed in Cook County Circuit Court on October 29, Case No. 2015-L-010969.
According to the complaint, Lillie Ree Gibson was prescribed Onglyza in 2010. In June 2011, she was diagnosed with heart failure. She was hospitalized twice in 2013 and died that year on October 31.
Gibson accuses AstraZeneca of negligence for failing to adequately warn patients about the increased risk of heart problems.
Concerns have grown significantly since the “SAVOR” clinical trial found a 27% increased risk of first-ever hospitalizations for heart failure among Onglyza patients. An FDA advisory panel recommended label updates and asked for more data on an increased risk of all-cause mortality also observed in SAVOR.
Any evidence linking diabetes drugs and heart problems is concerning. People with type-2 diabetes already have a higher risk of heart problems and certain medications can potentially increase this risk even further.
Last month, AstraZeneca was denied approval for a diabetes drug combining Onglyza with Farxiga (dapagliflozin). In May, the FDA warned that Farxiga and other SGLT2 inhibitors could lead to a life-threatening side effect known as diabetic ketoacidosis.
Do I have an Onglyza Lawsuit?
The Schmidt Firm, PLLC is currently accepting Onglyza induced injury cases in all 50 states. If you or somebody you know has been diagnosed with heart failure, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.